Aberrant expression of the CD8 antigen in B cell chronic lymphocytic leukaemia

A Espinosa1, P Bjørk, K Magnussen

  • 1Department of Immunology and Transfusion Medicine, University Hospital of Trondheim, St Olavs Hospital, Olav Kyrresg, Trondheim 17, 7006, Norway. aurora.espinosa@rit.no

Leukemia & Lymphoma
|April 15, 2003
PubMed

Insights

This study details a rare case of B cell chronic lymphocytic leukemia (B-CLL) with aberrant CD8 T cell marker expression. The patient responded well to treatment, showing a significant reduction in leukemia cells.

Area of Science:

  • Hematology
  • Immunology
  • Oncology

Background:

  • B cell chronic lymphocytic leukemia (B-CLL) is a common lymphoid malignancy.
  • Immunophenotyping is crucial for diagnosing and classifying B-CLL.
  • Aberrant antigen expression can occur in B-CLL, impacting prognosis and treatment.

Observation:

  • A 62-year-old female presented with enlarged lymph nodes and suspected B-CLL.
  • Flow cytometry revealed a typical B-CLL immunophenotype.
  • Aberrant expression of the T cell marker CD8 was detected on 64% of leukemic cells.

Findings:

  • The co-expression of CD8 on B-CLL cells is a rare finding.
  • The clinical significance and biological basis of this CD8 aberrant expression remain to be fully elucidated.
  • The patient exhibited a rapid and positive response to treatment.

Implications:

  • This case highlights the importance of comprehensive immunophenotyping in B-CLL diagnosis.
  • Understanding aberrant antigen expression may lead to novel therapeutic strategies.
  • Further research is needed to determine the prognostic and therapeutic implications of CD8 co-expression in B-CLL.

Related Concept Videos

Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Diversity of Antigen Receptors01:28

Diversity of Antigen Receptors

Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...